![]() |
市场调查报告书
商品编码
1871878
全球细胞培养肉类和鱼类市场:预测至2032年-按来源、产品形式、通路、技术、应用和地区进行分析Cell-Cultured Meat & Seafood Market Forecasts to 2032 - Global Analysis By Source (Poultry, Beef, Seafood, Pork, Duck and Exotic Meats), Product Format, Distribution Channel, Technology, Application and By Geography |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球细胞培养肉类和鱼类市场价值将达到 3.9382 亿美元,到 2032 年将达到 33.5425 亿美元,在预测期内的复合年增长率为 35.8%。
细胞培养肉类和鱼是一种利用在洁净、可控的实验室或工业环境中培养的活体动物细胞直接生产真正肉类的技术。无需饲养牲畜或捕捞鱼类,细胞即可生长成肌肉和脂肪组织,复製传统肉类的风味、营养和食用体验。这种创新方法解决了气候变迁影响、抗生素抗药性、动物福利和全球鱼类资源枯竭等关键问题。生物反应器、工程化生长因子和高效细胞培养系统的应用,使得细胞培养肉和鱼类能够稳定生产,不受季节和地理限制。人们对永续蛋白质日益增长的兴趣,促使Start-Ups和大型食品公司积极投资该领域。自动化技术的进步、培养基成本的下降以及相关法规的支持,正逐步为细胞培养肉和鱼的商业性化铺路。
根据《生物工程杂誌》(2024)的报导,利用细胞培养技术生产水产品是满足全球日益增长的鱼类蛋白需求的可行替代方案,目前鱼类蛋白占动物蛋白消费量的17%。鑑于目前90%的海洋鱼类资源捕捞量已超过永续水平,细胞培养水产养殖提供了一个永续的解决方案。
对永续蛋白质的需求日益增长
环境永续性是推动细胞培养肉类和鱼类产业扩张的重要因素。传统畜牧业和海洋捕捞会导致排放增加、栖息地丧失、水污染和过度捕捞。相较之下,细胞培养蛋白的生产只需占用极少的土地,用水量较少,碳足迹也显着降低。这项技术得到了具有气候意识的消费者、企业和政策制定者的支持,他们都在寻求建立更环保的食品体系。在国际社会致力于永续性和排放碳排放的推动下,各国政府和投资者正在资助生物反应器、培养基和可扩展生产工厂的创新。人们对生态系统破坏的日益关注,正在推动对清洁、负责任的蛋白质来源的需求,进而促进市场发展。
生产成本高且扩充性有限
限制市场扩张的关键因素是高成本和复杂的生产流程。培养肉依赖昂贵的生长因子、细胞株、工业生物反应器和受控设施,这显着增加了营运成本。此外,它还需要专业的科学家和工程师,这推高了人事费用。儘管新的方法正在降低成本,但许多国家仍然缺乏大规模生产所需的生物製造基础设施。商业化生产仍面临挑战,零售价格也高于传统动物性蛋白质。如果没有价格合理的原料、简化的工艺流程和稳健的供应链,培养肉产品很可能仍将局限于小规模规模试点和专卖店,而无法进入更广泛的食品市场。
生物製程的进步与成本的降低
持续的技术进步为培养肉生产商带来了强大的商业性优势。改良的培养基配方、优化的生物反应器和经济高效的支架材料减少了对昂贵原料的依赖,并降低了营运成本。透过自动化、机器人技术和数位化监控简化生产过程,提高了产品的均匀性、安全性和风味可重复性。研究机构和Start-Ups正在设计扩充性的工作流程,以提高细胞产量和改善质地,同时降低成本。随着生产系统的日益完善,预计零售价格将逐步接近传统肉品的价格。与大型食品公司、大学和原料供应商的合作正在帮助建立全球供应链网路。这些进步将使培养蛋白更具竞争力,并得到更广泛的应用。
来自植物性产品和传统肉品的竞争
培养肉公司身处竞争激烈的市场,植物基和传统肉品占据了商店地位。植物基品牌拥有大规模生产、低价格和较高的消费者认知度,因此进入门槛较低。同时,传统肉类价格实惠、接受度高,并有庞大的农业产业支持。如果培养肉产品无法在成本、口味熟悉度和供应方面与之竞争,消费者可能会继续选择他们现有的蛋白质来源。大型肉类公司也不断提高其永续性标准,并积极推广其环保倡议,这降低了消费者转向人造肉的紧迫性。这种竞争可能会限制培养肉的成长前景,并延缓其被主流市场接受的过程。
感染疾病为培养肉产业带来了挑战与机会。传统肉类生产面临供不应求、污染风险和工厂临时关闭等问题,促使消费者寻求更安全、更卫生的蛋白质来源。这种转变使得培养肉和鱼贝类获得了更多资金筹措和政策关注。同时,旅行限制和实验室关闭也延缓了实验测试、设备交付和规模化生产计划。疫情初期,Start-Ups新创企业面临营运成本上升和投资者信心下降的困境。然而,疫情也凸显了可控、无病害生产系统的优势。因此,培养肉作为一种具有韧性和安全保障的食品解决方案,获得了长期认可。
预测期内,家禽市场将占据最大的市场份额。
预计在预测期内,禽肉领域将占据最大的市场份额,因为鸡肉是一种广受欢迎且用途广泛的蛋白质来源,深受各地消费者的喜爱。与更复杂的肉类相比,培养禽肉细胞生长效率更高,技术挑战更少,从而能够顺利实现规模化生产并确保产品品质的一致性。许多新兴企业已推出鸡肉原型产品,包括一口大小、条状和混合型等多种形式,以适应现有的菜单和烹饪方法。此外,注重营养的消费者寻求更轻盈的动物性蛋白质替代品,也进一步推动了该领域的发展。食品品牌和快餐店热衷于试用培养鸡肉,预计这将加速其商业化进程,并提高主流市场的认知度。因此,与其他培养肉类别相比,禽肉预计将继续保持领先地位。
预计宠物食品细分市场在预测期内将呈现最高的复合年增长率。
预计在预测期内,宠物食品产业将呈现最高的成长率,这主要得益于消费者对宠物健康安全营养日益增长的需求。许多饲主正在摒弃传统产品和来源不明的肉类,转而选择透明且不伤害动物的原料。培养蛋白消除了污染风险,避免了使用抗生素,使其成为一种高端替代品,符合宠物人性化趋势。众多创新者正在研发犬猫的细胞培养食品和零食,推动了该品类的快速扩张。动物食品的核准流程通常比人类产品更为简便,这使得企业能够更快地将产品推向市场,从而有望实现强劲的复合年增长率。
北美预计将在整个预测期内占据最大的市场份额,这得益于其强大的科研生态系统、鼓励创新的文化以及早期商业化活动。研究机构和领先的食品科技公司正在快速开发细胞株、生物反应器和混合产品形式,吸引了大量投资者的资金。该地区的消费者对永续和无动物实验的蛋白质持开放态度,这促使餐厅和特色零售商探索新产品的推出。监管机构已开始修订安全和标籤框架,增强了生产商的信心。凭藉着经验丰富的人才、成熟的Start-Ups网络和良好的投资环境,北美将继续引领市场成长和技术进步。
在预测期内,亚太地区预计将呈现最高的复合年增长率,这主要得益于市场对价格合理、安全清洁蛋白质的需求不断增长。许多国家面临土地资源有限和对水产品高度依赖的困境,这推动了对培养肉替代品的投资。新加坡、中国、日本和韩国等国政府正在资助研究计画、提供津贴并支持监管流程,以增强食品安全。核准的加速和餐厅产品的上市提高了市场认知度和消费者兴趣。快速的都市化、永续性目标以及Start-Ups企业的积极涌入,都促进了亚太地区的强劲成长。因此,亚太地区正在崛起为最具活力且成长最快的区域市场。
According to Stratistics MRC, the Global Cell-Cultured Meat & Seafood Market is accounted for $393.82 million in 2025 and is expected to reach $3354.25 million by 2032 growing at a CAGR of 35.8% during the forecast period. Cell-cultured meat & seafood involves creating real meat directly from living animal cells, cultivated under clean, controlled laboratory or industrial conditions. Instead of raising livestock or catching fish, cells grow into muscle and fat tissues that replicate traditional flavors, nutrients, and culinary experience. This innovative approach addresses major concerns around climate impact, antibiotic resistance, animal welfare, and resource depletion from global fisheries. Use of bioreactors, engineered growth factors, and efficient cell-culturing systems supports consistent production without seasonal or geographical constraints. With rising interest in sustainable proteins, startups and major food companies are investing heavily. Enhanced automation, cheaper media, and supportive regulations are gradually paving the path toward commercial viability.
According to the Journal of Biological Engineering (2024), cell-cultivated seafood production is a viable alternative to meet rising global demand for fish protein, which currently accounts for 17% of total animal protein consumption. With 90% of marine fish stocks fished at or above sustainable levels, cellular aquaculture offers a sustainable solution.
Rising demand for sustainable protein
Environmental sustainability has become a powerful catalyst for the expansion of the cell-cultured meat & seafood industry. Conventional livestock and marine harvesting contribute to rising emissions, habitat loss, water contamination, and overfishing. In contrast, cultured protein can be produced with minimal land, reduced water inputs, and sharply lower carbon output. This technology appeals to climate-conscious consumers, businesses, and policymakers aiming to adopt greener food systems. With international commitments to sustainability and carbon reduction, governments and investors are funding innovation in bioreactors, growth media, and scalable production plants. As awareness of ecological damage intensifies, demand for clean and responsible protein sources strengthens, boosting market progress.
High production costs and limited scalability
A major limitation hindering market expansion is the expensive and technically complex production process. Cultured meat depends on costly growth factors, cell lines, industrial bioreactors, and controlled facilities that significantly increase operating expenses. The industry also requires expert scientists and engineers, raising labor costs. Although new methods are reducing expenses, many countries lack the required biomanufacturing infrastructure for mass production. Commercial-scale output is still difficult, causing retail prices to remain higher than traditional animal protein. Without cheaper inputs, streamlined processes, and strong supply chains, cultured products will continue to appear mainly in small trials and specialized outlets rather than widespread grocery markets.
Advancements in bioprocessing and cost reduction
Ongoing technological progress is creating strong commercial advantages for cultured meat manufacturers. Enhanced media formulations, optimized bioreactors, and cost-efficient scaffolds are reducing reliance on costly ingredients and lowering operational budgets. Automation, robotics, and digital monitoring streamline production steps, improving uniformity, safety, and flavor replication. Research institutes and startups are designing scalable workflows that enable higher cell yields and improved texture at reduced cost. As manufacturing systems upgrade, retail pricing can gradually approach that of conventional meat. Collaborations with major food companies, universities, and ingredient suppliers help build global supply networks. These advancements make cultured proteins more competitive and widely available.
Competition from plant-based and traditional meat
Cultured meat firms operate in a highly competitive landscape where plant-based and conventional meat products dominate shelf space. Plant-based brands benefit from mass production, lower pricing, and strong consumer recognition, making them easier to purchase. At the same time, traditional meat is affordable, well-accepted, and supported by large farming industries. If lab-grown products cannot match cost, flavor familiarity, or accessibility, buyers may continue choosing existing protein sources. Large meat corporations are also improving sustainability standards and advertising eco-friendly practices, reducing the urgency to switch. Such competition may restrict growth prospects for cultured meat and delay mainstream acceptance.
COVID-19 created both obstacles and opportunities for the cultured meat sector. Conventional meat production faced supply shortages, contamination risks, and temporary facility closures, prompting consumers to consider safer, hygienic protein sources. This shift encouraged greater funding and policy attention toward lab-grown meat and seafood. On the other hand, travel restrictions and laboratory shutdowns slowed experimental trials, equipment delivery, and scaling projects. Some startups struggled with higher operating expenses and limited investor confidence early in the pandemic. Yet, the situation highlighted the advantages of controlled, disease-free manufacturing systems. As a result, cultured meat gained long-term visibility as a resilient and secure food solution.
The poultry segment is expected to be the largest during the forecast period
The poultry segment is expected to account for the largest market share during the forecast period because chicken is a popular, versatile protein consumed across regions. Cultured poultry cells grow efficiently and require fewer engineering challenges than more complex meats, enabling smoother scale-up and product consistency. Many emerging companies are launching chicken-based prototypes such as bites, strips, and blended formats that fit existing menus and cooking methods. The segment gains additional momentum from nutrition-aware customers seeking lighter animal protein alternatives. Food brands and quick-service outlets show greater willingness to trial cultured chicken, which supports faster commercialization and mainstream visibility. As a result, poultry stays ahead of other cultured meat categories.
The pet food segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pet food segment is predicted to witness the highest growth rate, driven by consumer interest in healthier, safer nutrition for pets. Many owners are shifting away from conventional by-products and unknown meat sources, preferring transparent, cruelty-free ingredients. Cultured protein eliminates contamination risks and avoids antibiotics, providing a premium alternative that aligns with rising pet humanization trends. Numerous innovators are formulating cell-cultured meals and treats for dogs and cats, helping the category expand quickly. Because approval processes for animal food can be simpler than human products, companies can launch earlier and reach the market faster, supporting strong CAGR potential.
During the forecast period, the North America region is expected to hold the largest market share because of its strong scientific ecosystem, supportive innovation culture, and early commercialization activity. Research laboratories and pioneering food-tech companies are rapidly advancing cell lines, bioreactors, and hybrid product formats, attracting substantial funding from investors. Consumers in the region are open to sustainable and cruelty-free proteins, motivating restaurants and specialty retailers to test new product launches. Regulatory bodies have begun reviewing safety and labeling frameworks, boosting confidence among producers. With access to experienced talent, mature startup networks, and favorable investment conditions, North America continues to lead market growth and technological progress.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to increasing demand for affordable, safe, and clean protein. Many nations face limited land availability and heavy reliance on seafood, motivating investment in lab-grown alternatives. Governments in Singapore, China, Japan, and South Korea are funding research programs, offering grants, and supporting regulatory pathways to strengthen food security. Early approvals and restaurant-level product launches are improving market awareness and consumer interest. Rapid urban lifestyles, sustainability goals, and active startup participation contribute to strong expansion. As a result, Asia-Pacific is emerging as the most dynamic and fast-growing regional market.
Key players in the market
Some of the key players in Cell-Cultured Meat & Seafood Market include Shiok Meats Inc, Finless Foods, Inc., CULT Food Science Corp., Future Meat Technologies Ltd., Bene Meat Technologies, Forged by Vow Group Pty Ltd., Aleph Farms Ltd., Innocent Meat GmbH, Gourmey, Avant Meats Company Limited, Meatable B.V., Orbillion Bio, Inc., Neat Meatt Biotech Private Limited, BlueNalu, Inc. and LabFarm Sp. z o.o.
In October 2025, CULT Food Science Corp. announces that it has entered into a debt settlement agreement with an arm's-length creditor to settle outstanding indebtedness totaling $132,500. Pursuant to the Debt Settlement, the Company will issue an aggregate of 8,833,333 common shares at a deemed price of $0.015 per Share, representing the Company's 20-day volume-weighted average price.
In September 2025, BeneMeat has launched its Try & Share Program, offering EU citizens the opportunity to test dog treats containing cultivated meat while providing feedback on the products. The program represents the first consumer trial of cultivated meat products for pets in the European market.
In August 2022, Mirai Foods and Shiok Meats have entered into a strategic partnership agreement. The collaboration will enable the two innovators to exchange know-how and supplies to bring cultivated beef to Singapore. MIRAI FOODS will supply Gaia Foods with its one-of-a-kind bovine muscle and fat stem cells - the essential raw material for producing cultivated beef.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.